Because of its benefits, some people may continue using tirzepatide even during early pregnancy or after giving birth
doi:10.1210/jcem.86.8.7743
About 8% of people who take 6 weeks belly injections report constipation as an adverse event
However, as Mounjaro nears the end of its clinical trials, with an FDA decision expected by the end of 2023 or by early 2024, new reports of permanent gastrointestinal injuries after taking Mounjaro are being reported by users, and a growing number of potential Mounjaro lawsuits could derail the drug makers hopes for widespread use as a diet drug
(PubMed) Orhan Kilic B, Kilic S, Sahin Eroglu E, Gul E, Belen Apak FB
Our rigorous testing protocols, proper storage and shipping procedures and detailed documentation will give you confidence in your materials and results.More to come as research unfolds